Allarity Therapeutics, Inc. Convertible Notes Payable
Allarity Therapeutics, Inc. (ALLR) had Convertible Notes Payable of $1.35 million as of 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleNotesPayable · last filed 2026-03-30
- 2024-12-31: Convertible Notes Payable $1.35M.
- 2024-06-30: Convertible Notes Payable $1.32M.
- 2024-03-31: Convertible Notes Payable $1.32M.
- 2023-12-31: Convertible Notes Payable $1.30M.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2024-12-31 | $1.35M 10-K · filed 2026-03-30 | |
| 2024-06-30 | $1.32M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $1.32M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.30M 10-K · filed 2026-03-30 | |
| 2022-12-31 | $1.08M 10-K · filed 2025-03-31 | $2.63M 10-K · filed 2023-03-13 |
| 2021-12-31 | $1.00M 10-K · filed 2024-03-08 | $1.14M 10-K · filed 2022-05-17 |
| 2021-09-30 | $1.14M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.14M 10-Q · filed 2022-10-07 | |
| 2021-03-31 | $1.14M 10-Q · filed 2022-05-27 | |
| 2020-12-31 | $3.42M 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |